recombinant trypsinogen/chymotrypsinogen (Rec-PRP) / Propanc Biopharma - LARVOL DELTA

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal (The Manila Times) - "The findings demonstrate PRP exerts multifaceted effects. Results underscore the candidacy of PRP as a potential disruptor of the TME. Future clinical investigation is planned to validate the translational potential of PRP as an adjunct therapy for PDAC patients who no longer respond to standard treatment regimen....'We plan to undertake our Phase 1b study in advanced cancer patients suffering from solid tumors in Q3, 2026, and further announcements are anticipated'."

New P1 trial • Preclinical • Pancreatic Ductal Adenocarcinoma • Solid Tumor

Propanc Biopharma Engages Boutique Advisory Firm to Identify Strategic Investment Opportunities (Businesswire) - "Propanc Biopharma, Inc...today announced that a boutique advisory firm has been engaged to identify strategic investment opportunities primarily to fund the advancement of the Company’s lead product candidate, PRP, to the completion of the Company’s planned Phase I, First-In-Human study in advanced cancer patients suffering from solid tumors. Funds will also be utilized to advance the Company’s back up clinical candidate, Rec-PRP, a synthetic recombinant version of PRP, which will further enhance the potency and stability of the naturally derived proenzyme treatment. As part of the process, the opportunity to consider up-listing to a national US stock exchange will also be considered. The emerging boutique advisory firm currently has a $3B+ transaction history and access to a global network of investors the Company intends to fully utilize."

Financing • Oncology • Solid Tumor

"Propanc Biopharma Synthesizes Recombinant Trypsinogen & Chymotrypsinogen Via POP1 Joint Research & Drug Discovery Program https://t.co/wJK3kl2s5c" (@NewsFromBW)

"Propanc Biopharma Successfully Produces Synthetic Recombinant Trypsinogen Via POP1 Joint Research & Drug Discovery Program https://t.co/ixW8qa9vY2" (@NewsFromBW)